Related Experiment Video
Updated: Aug 29, 2025

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
ASXL1/2 mutations and myeloid malignancies
Edward A Medina1, Caroline R Delma2, Feng-Chun Yang3,4
1Division of Hematopathology, Department of Pathology and Laboratory Medicine, Joe R. and Teresa Lozano Long School of Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX, 78229-3900, USA. medinae2@uthscsa.edu.
Mutations in ASXL1 and ASXL2 epigenetic regulators impact hematopoietic stem cell function, contributing to myeloid malignancies like AML. Understanding these ASXL genes is crucial for prognosis and treatment strategies.
Area of Science:
- Hematology
- Epigenetics
- Molecular Biology
Background:
- Myeloid malignancies arise from genetic/epigenetic changes affecting hematopoietic stem cells (HSCs).
- Polycomb group (PcG) and Trithorax group (TrxG) proteins are key epigenetic regulators of stem cell function.
- Enhancers of Trithorax and Polycomb (ETP) proteins, including ASXL1 and ASXL2, modulate PcG/TrxG activity.
Purpose of the Study:
- To review the roles of ASXL1 and ASXL2 in normal and malignant hematopoiesis.
- To discuss the molecular mechanisms underlying ASXL gene function in myeloid malignancies.
- To highlight the prognostic significance of ASXL1 and ASXL2 mutations.
Main Methods:
- Review of findings from mouse model systems studying ASXL1 and ASXL2.
- Analysis of molecular mechanisms involving ASXL proteins in chromatin regulation.
- Correlation of ASXL gene mutations with specific myeloid malignancy subtypes and outcomes.
Main Results:
- ASXL1 mutations are frequent in myeloid malignancies and linked to poor prognosis.
- ASXL2 mutations are common in AML with t(8;21)/RUNX1-RUNX1T1.
- ASXL proteins are critical for assembling chromatin modification complexes and regulating gene expression.
Conclusions:
- ASXL1 and ASXL2 play significant roles in both normal hematopoiesis and the development of myeloid malignancies.
- Dysregulation of ASXL genes contributes to HSC dysfunction and disease progression.
- Further research into ASXL proteins may reveal therapeutic targets for myeloid cancers.
Related Concept Videos
Abnormal Proliferation
Sex-linked Disorders
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Pleiotropy
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Differentiation of Common Myeloid Progenitor Cells

